Accenture (NYSE: ACN) director Alan Jope awarded 14 RSUs

Rhea-AI Filing Summary

Jope Alan C. reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc director Alan C. Jope received a grant of 14 Class A ordinary shares in the form of Restricted Share Units. The award was made under anti-dilution provisions tied to previously granted RSU awards to reflect Accenture plc’s payment of a cash dividend. Following this grant, Jope directly holds 3,223 Class A ordinary shares.

Insider Trade Summary

Net Buyer: 14 shares

Net Buy 1 txn

Insider Jope Alan C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares F1	14	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 3,223 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Key Figures

RSU shares granted: 14 Class A ordinary shares Price per share: $0.0000 Shares owned after transaction: 3,223 Class A ordinary shares

3 metrics

RSU shares granted 14 Class A ordinary shares Grant of Restricted Share Units pursuant to anti-dilution provisions tied to cash dividend

Price per share $0.0000 Reported transaction price per share for the RSU grant

Shares owned after transaction 3,223 Class A ordinary shares Total direct holdings of Alan C. Jope following the RSU grant

Key Terms

Restricted Share Units (RSUs), anti-dilution provisions, cash dividend

3 terms

Restricted Share Units (RSUs) financial

"Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

anti-dilution provisions financial

"pursuant to the anti-dilution provisions of previously granted RSU awards"

Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.

cash dividend financial

"to reflect Accenture plc's payment of a cash dividend"

A cash dividend is a payment made by a company to its shareholders directly in money, usually on a regular schedule. It is a way for investors to receive a portion of the company's profits, similar to earning interest or a bonus for holding the company's stock. Cash dividends provide income to shareholders and can indicate the company's financial health and stability.

FAQ

What did Accenture (ACN) director Alan C. Jope report in this Form 4?

Alan C. Jope reported receiving 14 Class A ordinary shares of Accenture plc as a grant of RSUs. This grant adjusts previously awarded RSUs under anti-dilution provisions following Accenture’s payment of a cash dividend.

How many Accenture (ACN) shares does Alan C. Jope hold after this transaction?

After the reported RSU grant, Alan C. Jope directly holds 3,223 Class A ordinary shares of Accenture plc. This figure reflects his updated direct ownership position following the anti-dilution RSU adjustment.

What type of transaction did Alan C. Jope report for Accenture (ACN)?

The transaction is a grant or award acquisition of Class A ordinary shares via Restricted Share Units. It is coded as an “A” transaction, indicating a grant, award, or other acquisition rather than an open-market purchase or sale.

Why did Alan C. Jope receive additional RSUs in Accenture (ACN)?

The additional RSUs were granted pursuant to anti-dilution provisions in previously granted RSU awards. They adjust his equity awards to reflect Accenture plc’s payment of a cash dividend, maintaining the economic value of earlier grants.

Was Alan C. Jope’s Accenture (ACN) transaction under a Rule 10b5-1 plan?

The report indicates the Rule 10b5-1 checkbox is not marked as affirmative. The transaction is described as a compensation-related grant of RSUs rather than a trade executed under a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:47 PM Accepted by SEC EDGAR 08/17/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jope Alan C.

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/14/2026		A		14(1)	A	$0	3,223	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Allyson Retson, Attorney-in-Fact for Alan C. Jope	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)